囊性纤维化
医学
囊性纤维化跨膜传导调节器
粘液
慢性阻塞性肺病
氯离子通道
气道
肺
疾病
呼吸道疾病
炎症
病理生理学
病理
免疫学
离子通道
纤维化
跨膜蛋白
呼吸上皮
发病机制
内科学
呼吸系统
阻塞性肺病
生物信息学
肺病
哮喘
特发性肺纤维化
作者
Mark Dransfield,Steven Rowe,Claus F. Vogelmeier,Jadwiga Anna Wedzicha,Gerard J. Criner,MeiLan K. Han,Fernando J. Martínez,Peter Calverley
标识
DOI:10.1164/rccm.202109-2064tr
摘要
Chronic obstructive pulmonary disease (COPD) manifests with a variety of clinical presentations, reflecting its complex pathology. Currently, care focuses on symptom amelioration and prevention of complications and thus is generally tailored to disease severity rather than targeting specific pathophysiologic mechanisms. Chronic inflammation and mucus hypersecretion are key features of COPD. Epithelial ion channel dysfunction may be important, as it results in airway dehydration and defective host defense, contributing to chronic airway inflammation. Recent evidence suggests considerable similarities between COPD and cystic fibrosis (CF), a disease in which chloride ion channel dysfunction has been extensively studied (in particular CFTR [CF transmembrane conductance regulator]). Understanding commonalities between CF and COPD, and the role of CFTR in CF, may help in designing strategies targeting ion channel dysfunction and lead to new treatments with potential to alter the natural history of disease progression. Here, we review the roles of airway mucus and CFTR in normal lung function, the previously underestimated contribution of mucus stasis to the development of COPD, and the evidence for targeting CFTR to counteract mucus accumulation.
科研通智能强力驱动
Strongly Powered by AbleSci AI